Lam Research (NASDAQ:LRCX) Price Target Raised to $300.00

Lam Research (NASDAQ:LRCX) had its price objective boosted by equities researchers at Stifel Nicolaus from $280.00 to $300.00 in a report issued on Monday,MarketScreener reports. The firm currently has a “buy” rating on the semiconductor company’s stock. Stifel Nicolaus’ target price would suggest a potential upside of 13.78% from the stock’s previous close.

Other research analysts also recently issued research reports about the stock. Erste Group Bank downgraded shares of Lam Research from a “buy” rating to a “hold” rating in a research note on Thursday, April 2nd. B. Riley Financial restated a “buy” rating on shares of Lam Research in a report on Thursday, January 15th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $200.00 price objective (up from $175.00) on shares of Lam Research in a research report on Monday, December 15th. UBS Group set a $300.00 target price on Lam Research in a research note on Thursday, January 29th. Finally, Weiss Ratings reissued a “buy (b-)” rating on shares of Lam Research in a report on Friday. Twenty-seven analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $246.94.

Lam Research Price Performance

Shares of NASDAQ:LRCX opened at $263.66 on Monday. Lam Research has a 1-year low of $61.14 and a 1-year high of $268.23. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.26 and a quick ratio of 1.61. The business has a fifty day moving average price of $227.64 and a 200-day moving average price of $189.78. The company has a market capitalization of $329.25 billion, a PE ratio of 54.03, a PEG ratio of 2.81 and a beta of 1.78.

Lam Research (NASDAQ:LRCX) last announced its quarterly earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.17 by $0.10. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. The company had revenue of $5.34 billion for the quarter, compared to analysts’ expectations of $5.23 billion. During the same quarter in the previous year, the business posted $0.91 EPS. Lam Research’s revenue was up 22.1% compared to the same quarter last year. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. As a group, equities analysts expect that Lam Research will post 3.71 EPS for the current fiscal year.

Insiders Place Their Bets

In other Lam Research news, CFO Douglas R. Bettinger sold 50,057 shares of the business’s stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $224.03, for a total transaction of $11,214,269.71. Following the completion of the sale, the chief financial officer directly owned 1,081,705 shares in the company, valued at approximately $242,334,371.15. The trade was a 4.42% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Ava Harter sold 1,500 shares of the firm’s stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $222.66, for a total value of $333,990.00. Following the completion of the transaction, the insider owned 53,205 shares in the company, valued at approximately $11,846,625.30. This trade represents a 2.74% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 130,886 shares of company stock valued at $29,658,802. Company insiders own 0.31% of the company’s stock.

Institutional Investors Weigh In On Lam Research

Several hedge funds and other institutional investors have recently made changes to their positions in LRCX. Norges Bank bought a new stake in Lam Research during the fourth quarter valued at approximately $3,645,427,000. Price T Rowe Associates Inc. MD grew its holdings in Lam Research by 352.2% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,695,210 shares of the semiconductor company’s stock valued at $2,344,347,000 after purchasing an additional 10,666,540 shares during the period. Arrowstreet Capital Limited Partnership increased its position in Lam Research by 781.3% in the third quarter. Arrowstreet Capital Limited Partnership now owns 11,340,865 shares of the semiconductor company’s stock worth $1,518,542,000 after buying an additional 10,053,978 shares in the last quarter. Franklin Resources Inc. raised its stake in shares of Lam Research by 57.0% in the fourth quarter. Franklin Resources Inc. now owns 10,110,560 shares of the semiconductor company’s stock worth $1,730,724,000 after buying an additional 3,671,073 shares during the period. Finally, Corient Private Wealth LLC grew its stake in shares of Lam Research by 235.5% during the 4th quarter. Corient Private Wealth LLC now owns 5,199,441 shares of the semiconductor company’s stock valued at $890,040,000 after acquiring an additional 3,649,553 shares during the period. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Lam Research Company Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.